Researchers found an antibody that protects against a wide range of potentially lethal influenza viruses, advancing efforts to design of a universal vaccine.

Preparing a seasonal flu vaccine with the G186V mutation may prevent a vexing problem that commonly occurs during the vaccine manufacturing process.

The International AIDS Vaccine Initiative (IAVI) announced the start of a Phase I clinical trial to test a novel HIV vaccine candidate, an advance in vaccine design enabled by Scripps Research discoveries.

In a breakthrough with applicability across many flu strains, researchers find a potential small molecule that mimics antibodies to treat disease.